The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $137.32

Today's change+0.18 +0.13%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $137.32

Today's change+0.18 +0.13%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc up (U.S.)$0.18

USANA Health Sciences Inc closed up Friday by (U.S.)$0.18 or 0.13% to (U.S.)$137.32. Over the last five days, shares have gained 8.47% and 7.49% year to date. Shares have outperformed the S&P 500 by 6.63% during the last year.

Key company metrics

  • Open(U.S.) $137.31
  • Previous close(U.S.) $137.14
  • High(U.S.) $138.57
  • Low(U.S.) $136.68
  • Bid / Ask-- / --
  • YTD % change+7.49%
  • Volume119,061
  • Average volume (10-day)119,426
  • Average volume (1-month)104,206
  • Average volume (3-month)106,408
  • 52-week range(U.S.) $92.00 to (U.S.) $176.88
  • Beta1.17
  • Trailing P/E18.44×
  • P/E 1 year forward16.88×
  • Forward PEG1.69×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.45
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.12%

Based on its net profit margin of 10.12%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.21%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201604/02/2016Jan 02, 201601/02/2016Oct 03, 201510/03/2015Jul 04, 201507/04/2015
Revenue240233233233
Total other revenue--------
Total revenue240233233233
Gross profit198192192193
Total cost of revenue43404140
Total operating expense207197195194
Selling / general / administrative164157154154
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income34353839
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax33363839
Income after tax22242625
Income tax, total11121313
Net income22242625
Total adjustments to net income--------
Net income before extra. items22242625
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items22242625
Inc. avail. to common incl. extra. items22242625
Diluted net income22242625
Dilution adjustment------0
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share1.771.831.921.92
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.771.831.921.92